Physician profile
Larry Leslie
NPI 1669419990
$45,332.22
in general payments reported to CMS, 2019-2025
27 companies · $21K in 2025
The $21K reported for 2025 was more than what 93% of Interventional Cardiology providers received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $637 · 2020: $446 · 2021: $804 · 2022: $583 · 2023: $1,185 · 2024: $20K · 2025: $21K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $35K · Food and Beverage: $4,600 · Travel and Lodging: $3,627.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $34,634.75 |
| Food and Beverage | $4,600.41 |
| Travel and Lodging | $3,626.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $28,214.14 | 2022-2025 | Repatha, Repatha |
| Janssen Pharmaceuticals, INC | $11,825.60 | 2022-2024 | Xarelto |
| Edwards Lifesciences Corporation | $1,402.14 | 2019-2025 | Edwards Sapien 3 Ultra Transcatheter Heart Valve, Sapien 3 Ultra Resilia |
| Novartis Pharmaceuticals Corporation | $672.65 | 2022-2025 | |
| Alnylam Pharmaceuticals INC. | $534.13 | 2022-2025 | Onpattro |
| Abiomed | $447.48 | 2019-2024 | Impella |
| Cvrx, INC. | $386.71 | 2022-2025 | Barostim Neo System |
| Boston Scientific Corporation | $304.92 | 2020-2025 | Synergy, Watchman Flx, Watchman Access System |
| Boehringer Ingelheim Pharmaceuticals, INC. | $290.65 | 2022-2025 | Jardiance |
| Shockwave Medical, INC | $183.52 | 2021 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $168.02 | 2019-2025 | Lifevest |
| Abbott Laboratories | $145.63 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $145.33 | 2022-2025 | |
| Cardiva Medical, INC. | $127.55 | 2020-2023 | Cardiva Vascade 6/7f Vcs |
| Esperion Therapeutics, INC. | $90.16 | 2024-2025 | Nexletol |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $84.61 | 2024-2025 | Wegovy, Ozempic, Rybelsus |
| Medtronic, INC. | $62.16 | 2023-2025 | Corevalve Evolut R, Arctic Front Advance |
| Kestra Medical Technology Services, INC. | $59.20 | 2024-2025 | Assure Wcd |
| Philips North America LLC | $39.76 | 2024 | (Cm9) Amb Mon & Diag Und |
| Biohaven Pharmaceutical Holding Company LTD. | $27.16 | 2022 | |
| Inari Medical, INC. | $20.53 | 2024 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Pfizer INC. | $19.87 | 2025 | |
| Lilly USA, LLC | $18.24 | 2025 | Mounjaro |
| Exact Sciences Corporation | $17.85 | 2023 | Cologuard Collection Kit |
| Irhythm Technologies, INC. | $15.44 | 2022 | |
| Merck Sharp & Dohme LLC | $14.75 | 2023 | Verquvo, Belsomra |
| Kowa Pharmaceuticals America, INC. | $14.02 | 2023 | Livalo |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Larry Leslie listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.